CSBR logo

Champions Oncology (CSBR) Free Cash Flow

Annual FCF

-$6.97 M
-$8.07 M-733.91%

30 April 2024

CSBR Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$311.00 K
+$2.02 M+118.24%

31 July 2024

CSBR Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$2.00 M
+$4.97 M+71.27%

31 July 2024

CSBR TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CSBR Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-733.9%-28.7%+58.8%
3 y3 years-40.5%-53.0%+49.0%
5 y5 years-778.3%-47.0%-397.6%

CSBR Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-269.5%at low-91.9%+106.7%-134.1%+71.3%
5 y5 years-269.5%at low-91.9%+106.7%-134.1%+71.3%
alltimeall time-269.5%+28.5%-91.9%+106.7%-134.1%+79.5%

Champions Oncology Free Cash Flow History

DateAnnualQuarterlyTTM
July 2024
-
$311.00 K(-118.2%)
-$2.00 M(-71.3%)
Apr 2024
-$6.97 M(-733.9%)
-$1.71 M(+63.2%)
-$6.97 M(+3.8%)
Jan 2024
-
-$1.04 M(-339.7%)
-$6.72 M(+38.4%)
Oct 2023
-
$436.00 K(-109.4%)
-$4.86 M(+86.1%)
July 2023
-
-$4.66 M(+220.9%)
-$2.61 M(-337.3%)
Apr 2023
$1.10 M(-73.3%)
-$1.45 M(-277.3%)
$1.10 M(-61.3%)
Jan 2023
-
$819.00 K(-69.5%)
$2.84 M(-51.6%)
Oct 2022
-
$2.68 M(-382.6%)
$5.88 M(+52.4%)
July 2022
-
-$949.00 K(-427.2%)
$3.85 M(-6.3%)
Apr 2022
$4.11 M(-182.9%)
$290.00 K(-92.5%)
$4.11 M(+315.9%)
Jan 2022
-
$3.85 M(+481.9%)
$989.00 K(-125.2%)
Oct 2021
-
$662.00 K(-195.8%)
-$3.93 M(-6.8%)
July 2021
-
-$691.00 K(-75.6%)
-$4.22 M(-15.0%)
Apr 2021
-$4.96 M(-824.4%)
-$2.83 M(+165.4%)
-$4.96 M(+347.0%)
Jan 2021
-
-$1.07 M(-386.3%)
-$1.11 M(-1781.8%)
Oct 2020
-
$373.00 K(-126.0%)
$66.00 K(-76.4%)
July 2020
-
-$1.43 M(-240.8%)
$280.00 K(-59.1%)
Apr 2020
$685.00 K(-33.4%)
$1.02 M(+842.6%)
$685.00 K(-408.6%)
Jan 2020
-
$108.00 K(-81.6%)
-$222.00 K(-133.0%)
Oct 2019
-
$587.00 K(-157.1%)
$673.00 K(-638.4%)
July 2019
-
-$1.03 M(-1026.1%)
-$125.00 K(-112.2%)
Apr 2019
$1.03 M(-141.9%)
$111.00 K(-88.9%)
$1.03 M(+44.0%)
Jan 2019
-
$1.00 M(-575.4%)
$714.00 K(+781.5%)
Oct 2018
-
-$211.00 K(-268.8%)
$81.00 K(-84.7%)
July 2018
-
$125.00 K(-161.6%)
$528.00 K(-121.5%)
Apr 2018
-$2.46 M(-31.9%)
-$203.00 K(-154.9%)
-$2.46 M(+0.7%)
Jan 2018
-
$370.00 K(+56.8%)
-$2.44 M(-33.0%)
Oct 2017
-
$236.00 K(-108.3%)
-$3.64 M(-9.1%)
July 2017
-
-$2.86 M(+1428.3%)
-$4.01 M(+11.1%)
Apr 2017
-$3.61 M(-46.4%)
-$187.00 K(-77.6%)
-$3.61 M(-12.5%)
Jan 2017
-
-$834.00 K(+546.5%)
-$4.12 M(-0.6%)
Oct 2016
-
-$129.00 K(-94.7%)
-$4.14 M(-37.3%)
July 2016
-
-$2.46 M(+250.4%)
-$6.61 M(-1.7%)
Apr 2016
-$6.73 M(-31.0%)
-$701.00 K(-18.3%)
-$6.73 M(-16.6%)
Jan 2016
-
-$858.00 K(-67.0%)
-$8.07 M(-15.9%)
Oct 2015
-
-$2.60 M(+1.0%)
-$9.60 M(+1.1%)
July 2015
-
-$2.57 M(+25.9%)
-$9.50 M(-2.6%)
Apr 2015
-$9.75 M(+165.9%)
-$2.04 M(-14.4%)
-$9.75 M(+27.4%)
Jan 2015
-
-$2.39 M(-4.4%)
-$7.65 M(+9.2%)
Oct 2014
-
-$2.50 M(-11.5%)
-$7.01 M(+62.8%)
July 2014
-
-$2.82 M(-5229.1%)
-$4.30 M(+17.4%)
Apr 2014
-$3.67 M(-15.9%)
$55.00 K(-103.2%)
-$3.67 M(-25.4%)
Jan 2014
-
-$1.74 M(-946.6%)
-$4.91 M(+30.9%)
Oct 2013
-
$206.00 K(-109.4%)
-$3.75 M(-20.4%)
July 2013
-
-$2.18 M(+83.2%)
-$4.72 M(+8.2%)
Apr 2013
-$4.36 M(-24.1%)
-$1.19 M(+103.8%)
-$4.36 M(-9.9%)
Jan 2013
-
-$585.00 K(-22.7%)
-$4.84 M(-0.8%)
Oct 2012
-
-$757.00 K(-58.5%)
-$4.88 M(-17.9%)
July 2012
-
-$1.82 M(+9.2%)
-$5.94 M(+3.4%)
DateAnnualQuarterlyTTM
Apr 2012
-$5.75 M(+4033.8%)
-$1.67 M(+167.8%)
-$5.75 M(+23.0%)
Jan 2012
-
-$624.00 K(-65.7%)
-$4.67 M(+96.3%)
Oct 2011
-
-$1.82 M(+11.7%)
-$2.38 M(+81.2%)
July 2011
-
-$1.63 M(+173.5%)
-$1.31 M(+844.6%)
Apr 2011
-$139.00 K(-93.6%)
-$596.00 K(-135.7%)
-$139.00 K(-109.8%)
Jan 2011
-
$1.67 M(-320.9%)
$1.42 M(-215.4%)
Oct 2010
-
-$755.00 K(+65.6%)
-$1.23 M(-22.0%)
July 2010
-
-$456.00 K(-147.3%)
-$1.58 M(-27.7%)
Apr 2010
-$2.18 M(+115.4%)
$964.00 K(-198.0%)
-$2.18 M(-46.4%)
Jan 2010
-
-$984.00 K(-10.7%)
-$4.08 M(+62.7%)
Oct 2009
-
-$1.10 M(+3.8%)
-$2.50 M(+35.0%)
July 2009
-
-$1.06 M(+14.4%)
-$1.85 M(+82.9%)
Apr 2009
-$1.01 M(-236.1%)
-$928.00 K(-258.1%)
-$1.01 M(-1184.5%)
Jan 2009
-
$587.10 K(-229.9%)
$93.50 K(-49.3%)
Oct 2008
-
-$452.10 K(+104.6%)
$184.40 K(-62.8%)
July 2008
-
-$221.00 K(-223.1%)
$495.40 K(-37.4%)
Apr 2008
$745.00 K(-1049.0%)
$179.50 K(-73.5%)
$792.00 K(+33.0%)
Jan 2008
-
$678.00 K(-580.5%)
$595.50 K(-657.6%)
Oct 2007
-
-$141.10 K(-286.6%)
-$106.80 K(-771.7%)
July 2007
-
$75.60 K(-544.7%)
$15.90 K(-120.3%)
Apr 2007
-$78.50 K(-16.5%)
-$17.00 K(-30.0%)
-$78.50 K(-4.3%)
Jan 2007
-
-$24.30 K(+32.1%)
-$82.00 K(+0.5%)
Oct 2006
-
-$18.40 K(-2.1%)
-$81.60 K(-5.0%)
July 2006
-
-$18.80 K(-8.3%)
-$85.90 K(-8.6%)
Apr 2006
-$94.00 K(+164.0%)
-$20.50 K(-14.2%)
-$94.00 K(+126.0%)
Jan 2006
-
-$23.90 K(+5.3%)
-$41.60 K(+74.1%)
Oct 2005
-
-$22.70 K(-15.6%)
-$23.90 K(-66.1%)
July 2005
-
-$26.90 K(-184.3%)
-$70.60 K(+98.3%)
Apr 2005
-$35.60 K(-49.6%)
$31.90 K(-614.5%)
-$35.60 K(+28.5%)
Jan 2005
-
-$6200.00(-91.1%)
-$27.70 K(-52.4%)
Oct 2004
-
-$69.40 K(-956.8%)
-$58.20 K(+67.2%)
July 2004
-
$8100.00(-79.6%)
-$34.80 K(-50.7%)
Apr 2004
-$70.60 K(-72.6%)
$39.80 K(-208.4%)
-$70.60 K(-36.7%)
Jan 2004
-
-$36.70 K(-20.2%)
-$111.60 K(-35.9%)
Oct 2003
-
-$46.00 K(+66.1%)
-$174.20 K(-25.2%)
July 2003
-
-$27.70 K(+2208.3%)
-$232.90 K(-9.5%)
Apr 2003
-$257.30 K(+446.3%)
-$1200.00(-98.8%)
-$257.30 K(+111.1%)
Jan 2003
-
-$99.30 K(-5.2%)
-$121.90 K(+5.4%)
Oct 2002
-
-$104.70 K(+101.0%)
-$115.60 K(+32.0%)
July 2002
-
-$52.10 K(-138.8%)
-$87.60 K(+86.0%)
Apr 2002
-$47.10 K(-142.4%)
$134.20 K(-244.3%)
-$47.10 K(-158.0%)
Jan 2002
-
-$93.00 K(+21.3%)
$81.20 K(+19.2%)
Oct 2001
-
-$76.70 K(+561.2%)
$68.10 K(-27.9%)
July 2001
-
-$11.60 K(-104.4%)
$94.40 K(-14.9%)
Apr 2001
$111.00 K(-449.1%)
$262.50 K(-347.4%)
$110.90 K(-173.2%)
Jan 2001
-
-$106.10 K(+110.5%)
-$151.60 K(+233.2%)
Oct 2000
-
-$50.40 K(-1128.6%)
-$45.50 K(-1028.6%)
July 2000
-
$4900.00
$4900.00
Apr 2000
-$31.80 K
-
-

FAQ

  • What is Champions Oncology annual free cash flow?
  • What is the all time high annual FCF for Champions Oncology?
  • What is Champions Oncology annual FCF year-on-year change?
  • What is Champions Oncology quarterly free cash flow?
  • What is the all time high quarterly FCF for Champions Oncology?
  • What is Champions Oncology quarterly FCF year-on-year change?
  • What is Champions Oncology TTM free cash flow?
  • What is the all time high TTM FCF for Champions Oncology?
  • What is Champions Oncology TTM FCF year-on-year change?

What is Champions Oncology annual free cash flow?

The current annual FCF of CSBR is -$6.97 M

What is the all time high annual FCF for Champions Oncology?

Champions Oncology all-time high annual free cash flow is $4.11 M

What is Champions Oncology annual FCF year-on-year change?

Over the past year, CSBR annual free cash flow has changed by -$8.07 M (-733.91%)

What is Champions Oncology quarterly free cash flow?

The current quarterly FCF of CSBR is $311.00 K

What is the all time high quarterly FCF for Champions Oncology?

Champions Oncology all-time high quarterly free cash flow is $3.85 M

What is Champions Oncology quarterly FCF year-on-year change?

Over the past year, CSBR quarterly free cash flow has changed by -$125.00 K (-28.67%)

What is Champions Oncology TTM free cash flow?

The current TTM FCF of CSBR is -$2.00 M

What is the all time high TTM FCF for Champions Oncology?

Champions Oncology all-time high TTM free cash flow is $5.88 M

What is Champions Oncology TTM FCF year-on-year change?

Over the past year, CSBR TTM free cash flow has changed by +$2.85 M (+58.75%)